Pyrazinylpyridines useful for the treatment of proliferative diseases

Details for Australian Patent Application No. 2010291199 (hide)

Owner Novartis AG

Inventors Barsanti, Paul A.; Hu, Cheng; Pfister, Keith B.; Sendzik, Martin; Sutton, James

Agent Davies Collison Cave

Pub. Number AU-A-2010291199

PCT Pub. Number WO2011/026904

Priority 61/275,938 04.09.09 US; 61/284,962 28.12.09 US

Filing date 2 September 2010

Wipo publication date 10 March 2011

International Classifications

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/497 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

8 March 2012 PCT application entered the National Phase

  PCT publication WO2011/026904 Priority application(s): WO2011/026904

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010291203-An auditory test and compensation method

2010291195-Full aperture beverage can end